Patents by Inventor Takenao Odagami

Takenao Odagami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING EYE DISORDERS
    Publication number: 20150284393
    Abstract: The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of ?-catenin. The disclosure also relates to applications in the treatment of ophthalmic conditions, such as macular degeneration and glaucoma, and pharmaceutical compositions comprising such alpha helix mimetic ?-catenin inhibitors.
    Type: Application
    Filed: October 21, 2013
    Publication date: October 8, 2015
    Applicant: PRISM Pharma Co., Ltd.
    Inventors: Hiroyuki Kouji, Takenao Odagami
  • TREATMENT OF HYPERPROLIFERATIVE AND PRE-CANCEROUS SKIN DISEASES USING AN INHIBITOR OF CBP/CATENIN
    Publication number: 20150283145
    Abstract: The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of ?-catenin. The disclosure also relates to applications in the treatment of hyperproliferative and pre-cancerous skin conditions including actinic keratosis and psoriasis, and pharmaceutical compositions comprising such alpha helix mimetic ?-catenin inhibitors.
    Type: Application
    Filed: October 21, 2013
    Publication date: October 8, 2015
    Applicant: PRISM Pharma Co., Ltd.
    Inventors: Hiroyuki Kouji, Takenao Odagami
  • TREATMENT OF SCLERODERMA USING AN INHIBITOR OF CBP/CATENIN
    Publication number: 20150274751
    Abstract: The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of ?-catenin. The disclosure also relates to applications in the treatment of scleroderma, including diffuse systemic sclerosis and limited systemic sclerosis, and pharmaceutical compositions comprising such alpha helix mimetic ?-catenin inhibitors.
    Type: Application
    Filed: October 21, 2013
    Publication date: October 1, 2015
    Applicant: PRISM PHARMA CO., LTD.
    Inventors: Hiroyuki Kouji, Takenao Odagami
  • Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions
    Patent number: 9126981
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: September 8, 2015
    Assignee: PRISM BioLab Co., Ltd.
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • Alpha helix mimetics and methods relating thereto
    Patent number: 9040531
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a chemical library relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: May 26, 2015
    Assignee: PRISM BioLab Co., Ltd.
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji
  • METHOD FOR TREATING TYPE I AND TYPE II DIABETES
    Publication number: 20140275295
    Abstract: The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of ?-catenin. The disclosure also relates to applications in the treatment of diabetes and diabetic conditions such as diabetic neuropathy, and pharmaceutical compositions comprising such alpha helix mimetic ?-catenin inhibitors.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 18, 2014
    Inventors: Hiroyuki Kouji, Takenao Odagami
  • ALPHA HELIX MIMETIC COMPOSITIONS FOR TREATING CANCER AND OTHER CBP/CATENIN-MEDIATED DISEASES AND CONDITIONS
    Publication number: 20140221657
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: PRISM BioLab Corporation
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions
    Patent number: 8691819
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: April 8, 2014
    Assignee: PRISM BioLab Corporation
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20140051706
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: February 27, 2012
    Publication date: February 20, 2014
    Applicant: PRISM PHARMA CO., LTD.
    Inventors: Hiroyuki Kouji, Takenao Odagami
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20130267482
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: June 3, 2013
    Publication date: October 10, 2013
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji
  • Alpha helix mimetics and methods relating thereto
    Patent number: 8455488
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: June 4, 2013
    Assignee: PRISM BioLab Corporation
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20120088770
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a chemical library relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: May 7, 2010
    Publication date: April 12, 2012
    Applicant: Prism BioLab Corporation
    Inventors: Takenao Odagami, Yiji Kogami, Hiroyuki Kouji
  • ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER
    Publication number: 20110263607
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: October 14, 2009
    Publication date: October 27, 2011
    Applicant: PRISM BIOLAB CORPORATION
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20110092459
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: June 5, 2009
    Publication date: April 21, 2011
    Applicant: PRISM Biolab Corporation
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji